pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
alitretinoin
Panretin (alitretinoin)
Kaposi Sarcoma
Galephar Pharmaceutical Research Inc
5 catalysts
Phase 3
bevacizumab
Avastin (bevacizumab)
Melanoma
Vascular endothelial growth factor A, long form
F. Hoffmann-La Roche Ltd
5 catalysts
Marketed
capivasertib
Truqap (capivasertib)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Serine/threonine-protein kinase AKT
← prev
page 3 of 62
next →
131
Pain89
Neurology1
$AZNASTRAZENECA PLC
5 catalysts
Marketed
epcoritamab
Epkinly (epcoritamab-bsyp)
Diffuse Large B-Cell Lymphoma
Genmab AS
5 catalysts
Marketed
loncastuximab tesirine
Zynlonta (loncastuximab tesirine-lpyl)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD19
$ADCTADC Therapeutics SA
5 catalysts
Marketed
mogamulizumab
Poteligeo (mogamulizumab)
Peripheral T-Cell Lymphomas (PTCL)
C-C chemokine receptor type 4
Kyowa Kirin Co Ltd
5 catalysts
Marketed
niraparib
Zejula (niraparib)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Poly [ADP-ribose] polymerase 2Poly [ADP-ribose] polymerase 1
$JNJJOHNSON & JOHNSON
5 catalysts
Marketed
FULVESTRANT
FULVESTRANT (FULVESTRANT)
Hormone Sensitive Breast Cancer
Eagle Pharmaceuticals Inc
4 catalysts
Marketed
IFOSFAMIDE
IFOSFAMIDE (IFOSFAMIDE)
Germinomatous (Seminomatous) Germ Cell Tumors
Baxter Healthcare Corp
4 catalysts
Marketed
OXALIPLATIN
OXALIPLATIN (OXALIPLATIN)
Colon Cancer
Ingenus Pharmaceuticals LLC
4 catalysts
Marketed
lutetium Lu 177 vipivotide tetraxetan
Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
Hormone-Sensitive Prostate Cancer
Glutamate carboxypeptidase 2
$NVSNOVARTIS AG
4 catalysts
Marketed
momelotinib dihydrochloride
Ojjaara (momelotinib dihydrochloride)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
GlaxoSmithKline LLC
4 catalysts
Marketed
polatuzumab vedotin
Polivy (polatuzumab vedotin-piiq)
Diffuse Large B-Cell Lymphoma
Genentech Inc
4 catalysts
Marketed
relugolix
Orgovyx (relugolix)
Prostate Cancer
Sumitomo Pharma America Inc
4 catalysts
Marketed
tisotumab vedotin
Tivdak (tisotumab vedotin-tftv)
Bladder Cancer
Tissue factorTubulin
Genmab AS
4 catalysts
Marketed
ANAGRELIDE HYDROCHLORIDE
ANAGRELIDE HYDROCHLORIDE (ANAGRELIDE HYDROCHLORIDE)
Thrombosis
Takeda Pharmaceuticals USA Inc
3 catalysts
Marketed
Alimta
Alimta (pemetrexed disodium)
Malignant Pleural Mesothelioma
Lilly USA LLC
3 catalysts
Marketed
ET-800
HYDROCORTISONE (hydrocortisone)
Adrenal Insufficiency
$ETONEton Pharmaceuticals, Inc.
3 catalysts
Marketed
GEMCITABINE HYDROCHLORIDE
GEMCITABINE HYDROCHLORIDE (GEMCITABINE HYDROCHLORIDE)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
DNA polymerase (alpha/delta/epsilon)Ribonucleoside-diphosphate reductase RR1
$JNJJOHNSON & JOHNSON
3 catalysts
Marketed
capecitabine
Capecitabine (capecitabine)
Colon Cancer
Armas Pharmaceuticals Inc
3 catalysts
Marketed
cyclophosphamide
Cyclophosphamide (cyclophosphamide [INN])
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Long Grove Pharmaceuticals LLC
3 catalysts
Marketed
ensartinib hydrochloride
Ensacove (ensartinib hydrochloride)
Non-Small Cell Lung Cancer
Xcovery Holdings Inc
3 catalysts
Marketed
futibatinib
Lytgobi (futibatinib)
Bile Duct Cancer (Cholangiocarcinoma)
Fibroblast growth factor receptor
Taiho Oncology Inc
3 catalysts
Marketed
glofitamab
Columvi (glofitamab-gxbm)
Mantle Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
inavolisib
Itovebi (inavolisib)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
lazertinib mesylate
Lazcluze (lazertinib mesylate)
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
$JNJJOHNSON & JOHNSON
3 catalysts
Marketed
mosunetuzumab
Lunsumio Velo (mosunetuzumab-axgb)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
Genentech Inc
3 catalysts
Marketed
quizartinib dihydrochloride
Vanflyta (quizartinib dihydrochloride)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Daiichi Sankyo Co Ltd
3 catalysts
Marketed
(abiraterone acetate + niraparib)
Akeega ((abiraterone acetate + niraparib))
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
2 catalysts
Marketed
(amivantamab + hyaluronidase (human recombinant))
Rybrevant Faspro ((amivantamab + hyaluronidase-rhu (human recombinant)))
Recurrent Head And Neck Squamous Cell Carcinoma
$JNJJOHNSON & JOHNSON
2 catalysts